Moleculin Biotech
Price & Volume
Stats
See more52W Range | $0.25-$3.33 |
Market Cap | $24.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.74 |
News
See moreYahoo Finance • 5 days ago
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
Yahoo Finance • 10 days ago
Moleculin Biotech files to sell 64.86M shares of common stock by selling shareholder
Yahoo Finance • 21 days ago
Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial
Yahoo Finance • 22 days ago
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
About
CEO | Mr. Walter V. Klemp |
CFO | Mr. Jonathan P. Foster CPA |
Address | 5300 Memorial Drive, Houston, TX, United States, 77007 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
